Anemia, Hemolytic, Autoimmune  >>  Soliris (eculizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
DECADE, NCT01303952 / 2009-016966-97: Therapy of Chronic Cold Agglutinin Disease With Eculizumab

Completed
2
13
Europe
Eculizumab
University Hospital, Essen, Alexion Pharmaceuticals
Cold Agglutinin Disease
09/14
06/15

Download Options